Radionuclide Therapy in Rohtak

I-131 radioiodine Therapy

  • Hyperthyroidism: Treatment for Graves' disease and toxic nodular goiter
  • Differentiated Thyroid Cancer: Ablation of residual thyroid tissue and treatment of metastatic disease- nodal, lungs, skeletal

Lutetium-Lu-177 DOTATATE(PRRT therapy)

metastatic neuroendocrine tumors grade 1, 2

Lutetium-Lu-177 PSMA therapy

metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy

Lutetium-Lu-177 FAPI therapy

Advanced cancers with FAPI PET positivity with exhausted options- sarcomas, breast, ovary, pancreas, lung.

Terbium-161 DOTA

therapy– neuroendocrine tumors

Terbium-161 PSMA

therapy– metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy.

Actinium 225 PSMA

therapy– metastatic castrate resistant prostate cancer- post ARPI, pre and post chemotherapy

Actinium 225-DOTA

therapy– neuroendocrine tumors

Lutetium-Lu-177 EDTMP therapy

pain palliation therapy for osteoblastic skeletal metastasis
Call Now Button